Trial Profile
Evaluation of Post Injection Inflammation and Pain After Ranibizumab vs Aflibercept Intravitreal Injections
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 08 Mar 2016
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary) ; Aflibercept
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 08 May 2015 New trial record